- Received FDA Fast Track Designation for DYNE-101 in DM1 -
Dyne Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Seeking Alpha / 2 hours from now 2 Views
Seeking Alpha / 2 hours from now 2 Views
- Received FDA Fast Track Designation for DYNE-101 in DM1 -
Comments